What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Genome-based Drug Discovery

PUBLISHER: 360iResearch | PRODUCT CODE: 1591901

PUBLISHER: 360iResearch | PRODUCT CODE: 1591901

Humanized Mouse & Rat Model Market by Type (Humanized Mouse Model, Humanized Rat Model), Application (Hematopoiesis, Immunology & Infectious Diseases, Neuroscience), End-User - Global Forecast 2025-2030

PUBLISHED: October 31, 2024

PAGES: 198 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The Humanized Mouse & Rat Model Market was valued at USD 257.38 million in 2023, expected to reach USD 275.91 million in 2024, and is projected to grow at a CAGR of 7.33%, to USD 422.57 million by 2030.

The humanized mouse and rat model market is an integral segment of biomedical research, geared towards developing and testing viable therapeutic strategies for complex human diseases. This scope encompasses genetically engineered rodents that carry functioning human genes, tissues, or cells, providing an in-vivo model conforming to human biological and pathological phenomena. The necessity for these models is profound in understanding disease mechanisms, drug discovery, and personalized medicine, extending to applications in oncology, immunology, and infectious diseases. End-use domains stretch across academic and research institutions, pharmaceutical and biotechnology companies, and contract research organizations.

KEY MARKET STATISTICS
Base Year [2023]	USD 257.38 million
Estimated Year [2024]	USD 275.91 million
Forecast Year [2030]	USD 422.57 million
CAGR (%)	7.33%

Key growth factors include the increasing prevalence of chronic diseases, the urgency for novel therapeutic solutions, and advancing genomic technologies enhancing model development. Simultaneously, ethical concerns and high costs challenge market expansion. Opportunities arise from ongoing innovations in CRISPR and other gene-editing technologies, which potentially reduce development times and costs while increasing the precision of genetic humanization, allowing organizations to advance drug testing with higher reliability. However, market players must navigate stringent regulatory frameworks and overcome technical hurdles associated with humanizing complex genetic and immunological traits of rodents.

Innovations lie in enhancing model sophistication through multi-gene humanization and integrating human immune components, offering improved insights into human-specific responses to therapies. Collaborative synergies among academic, clinical, and industrial sectors would catalyze enhanced model platforms, accelerating translational research. For market players, a strategic focus on building portfolios of more comprehensive and highly specialized humanized models can unlock competitive advantages. Additionally, participating in partnerships leveraging AI and computational models could revolutionize predictive analytics, thus maximizing model utility in drug discovery.

In conclusion, while promising opportunities exist, stakeholders must leverage technological advancements and strategic collaborations to mitigate prevailing obstacles, thus ensuring sustained market growth and fulfilling the growing demand for effective human translational systems in biomedical research.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Humanized Mouse & Rat Model Market

The Humanized Mouse & Rat Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increasing number of biomedical research and drug development activities
- Emerging focus toward personalized medicine and precision therapeutics
- Rising demand owing to regulatory requirements and ethical considerations
Market Restraints
- Complex model development and validation process of humanized mouse & rats
Market Opportunities
- Growing advancements in genetic engineering technologies
- Integration of human organoids and organ-on-a-chip technologies with humanized mouse and rat models
Market Challenges
- Limitations in recapitulating human physiology

Porter's Five Forces: A Strategic Tool for Navigating the Humanized Mouse & Rat Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Humanized Mouse & Rat Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Humanized Mouse & Rat Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Humanized Mouse & Rat Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Humanized Mouse & Rat Model Market

A detailed market share analysis in the Humanized Mouse & Rat Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Humanized Mouse & Rat Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Humanized Mouse & Rat Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Humanized Mouse & Rat Model Market

A strategic analysis of the Humanized Mouse & Rat Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Humanized Mouse & Rat Model Market, highlighting leading vendors and their innovative profiles. These include Aragen Life Sciences, Beijing Vitalstar Biotechnology Co., Ltd., BIOCYTOGEN, Champions Oncology, Inc., Charles River Laboratories International, Inc., Crown Bioscience, Inc., Cyagen US Inc., GemPharmatech, genOway, Harbour BioMed, Hera BioLabs, inGenious Targeting Laboratory, Inc., Oncodesign Precision Medicine, Ozgene Pty Ltd., Pharmatest Services Oy, Taconic Biosciences, Inc., The Jackson Laboratory, TransCure Bioservices, and Vivo Bio Tech Ltd..

Market Segmentation & Coverage

This research report categorizes the Humanized Mouse & Rat Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Type, market is studied across Humanized Mouse Model and Humanized Rat Model. The Humanized Mouse Model is further studied across BLT Model, Hu-PBL-scid Model, and Hu-SRC-scid Model.
Based on Application, market is studied across Hematopoiesis, Immunology & Infectious Diseases, Neuroscience, Oncology, and Toxicology.
Based on End-User, market is studied across Academic & Research Facilities, Contract research & Manufacturing Organizations, and Pharmaceutical & Biotechnology Companies.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-961BA04A2E3A

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing number of biomedical research and drug development activities
  - 5.1.1.2. Emerging focus toward personalized medicine and precision therapeutics
  - 5.1.1.3. Rising demand owing to regulatory requirements and ethical considerations
- 5.1.2. Restraints
  - 5.1.2.1. Complex model development and validation process of humanized mouse & rats
- 5.1.3. Opportunities
  - 5.1.3.1. Growing advancements in genetic engineering technologies
  - 5.1.3.2. Integration of human organoids and organ-on-a-chip technologies with humanized mouse and rat models
- 5.1.4. Challenges
  - 5.1.4.1. Limitations in recapitulating human physiology
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Humanized Mouse & Rat Model Market, by Type

6.1. Introduction
6.2. Humanized Mouse Model
- 6.2.1. BLT Model
- 6.2.2. Hu-PBL-scid Model
- 6.2.3. Hu-SRC-scid Model
6.3. Humanized Rat Model

7. Humanized Mouse & Rat Model Market, by Application

7.1. Introduction
7.2. Hematopoiesis
7.3. Immunology & Infectious Diseases
7.4. Neuroscience
7.5. Oncology
7.6. Toxicology

8. Humanized Mouse & Rat Model Market, by End-User

8.1. Introduction
8.2. Academic & Research Facilities
8.3. Contract research & Manufacturing Organizations
8.4. Pharmaceutical & Biotechnology Companies

9. Americas Humanized Mouse & Rat Model Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Humanized Mouse & Rat Model Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Humanized Mouse & Rat Model Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Aragen Life Sciences
2. Beijing Vitalstar Biotechnology Co., Ltd.
3. BIOCYTOGEN
4. Champions Oncology, Inc.
5. Charles River Laboratories International, Inc.
6. Crown Bioscience, Inc.
7. Cyagen US Inc.
8. GemPharmatech
9. genOway
10. Harbour BioMed
11. Hera BioLabs
12. inGenious Targeting Laboratory, Inc.
13. Oncodesign Precision Medicine
14. Ozgene Pty Ltd.
15. Pharmatest Services Oy
16. Taconic Biosciences, Inc.
17. The Jackson Laboratory
18. TransCure Bioservices
19. Vivo Bio Tech Ltd.

Product Code: MRR-961BA04A2E3A

LIST OF FIGURES

FIGURE 1. HUMANIZED MOUSE & RAT MODEL MARKET RESEARCH PROCESS
FIGURE 2. HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. HUMANIZED MOUSE & RAT MODEL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. HUMANIZED MOUSE & RAT MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. HUMANIZED MOUSE & RAT MODEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. HUMANIZED MOUSE & RAT MODEL MARKET DYNAMICS
TABLE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BLT MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HU-PBL-SCID MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HU-SRC-SCID MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HEMATOPOIESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY & INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NEUROSCIENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ACADEMIC & RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 39. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 43. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 61. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 65. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 73. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. JAPAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 97. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. THAILAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 110. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. DENMARK HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 114. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. EGYPT HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 118. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FINLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 122. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FRANCE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ITALY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 146. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. NORWAY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 150. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. POLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 154. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. QATAR HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 170. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SPAIN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 182. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. TURKEY HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED MOUSE MODEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. HUMANIZED MOUSE & RAT MODEL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 193. HUMANIZED MOUSE & RAT MODEL MARKET, FPNV POSITIONING MATRIX, 2023